Novo Nordisk A Net Income per Employee (NVO), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Novo Nordisk A  (NYSE: NVO)
 

Novo Nordisk A Net Income per Employee

NVO's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 85.56% in the first quarter 2026, year on year to cumulative value of $30,284 million, and with 69,505 employees, Novo Nordisk A's income per employee grew on trailing twelve month basis to $ 435,715, this is below the company average income per employee.
The Healthcare sector has seen employees of 8 other companies achieving higher income per employee. While Novo Nordisk A's total ranking has deteriorated compared to the previous quarter from to 183.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVO Net Income per Employee (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Net Income Change 85.56 % 5.93 % -22.09 % 39.24 % 10.81 %
Net Income per Employee (TTM) $ 435,715 385,259 372,764 385,542 369,207
NVO's Total Ranking # 183 # # # #
Seq. Net Income Change -50.99 % 395.41 % -22.25 % -1.72 % -72.02 %

NVO Company Profile >> Back to NVO Efficiency Comparisons >> Compare NVO Net Income per Employee to its Competitors

NVO Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 14
Overall Market # 183

Net Income per Employee Statistics
High Average Low
$ 1,473,764 $ 448,609 $ 84,027
(Dec 31 2025)   (Dec 31 2019)







Companies with similar Income per Employee for 12 month ending Mar 31 2026, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2026Number of Employees Mar 31 2026
Elite Pharmaceuticals Inc   690,349.02 $ 44.873  Million 65 
Illumina Inc   666,406.25 $ 853.000  Million 1,280 
Engene Therapeutics Inc   623,048.78 $ 51.090  Million 82 
Spero Therapeutics Inc   609,400.00 $ 15.235  Million 25 
Amgen Inc   600,000.00 $ 7,800.000  Million 13,000 
Vaxart Inc   570,723.08 $ 37.097  Million 65 
Entera Bio Ltd   562,590.91 $ 12.377  Million 22 
Gilead Sciences Inc   542,117.65 $ 9,216.000  Million 17,000 
Soleno Therapeutics Inc  527,692.31 $ 96.040  Million 182 
Eli Lilly And Company  505,534.00 $ 25,276.700  Million 50,000 
Incyte Corporation  503,437.76 $ 1,431.777  Million 2,844 
Harmony Biosciences Holdings inc   496,979.52 $ 145.615  Million 293 
Omeros Corporation  492,400.00 $ 86.170  Million 175 
Sanuwave Health Inc   487,418.18 $ 26.808  Million 55 
Acadia Pharmaceuticals Inc   470,739.35 $ 375.650  Million 798 
Siga Technologies Inc  412,920.69 $ 20.233  Million 49 
Black Hawk Acquisition Corporation  405,491.50 $ 0.811  Million 2 
Neurocrine Biosciences Inc   334,300.00 $ 668.600  Million 2,000 
Abeona Therapeutics Inc   292,641.59 $ 66.137  Million 226 
Regeneron Pharmaceuticals Inc   287,047.37 $ 4,423.400  Million 15,410 
Adma Biologics Inc   255,570.32 $ 165.354  Million 647 
Indivior Pharmaceuticals Inc   252,000.00 $ 252.000  Million 1,000 
Dariohealth Corp   246,884.85 $ 40.736  Million 165 
Lantheus Holdings Inc   233,890.19 $ 279.031  Million 1,193 
Sarepta Therapeutics Inc   232,857.49 $ 194.436  Million 835 
Interpace Biosciences Inc   231,852.94 $ 23.649  Million 102 
Alnylam Pharmaceuticals Inc   228,506.40 $ 571.266  Million 2,500 
Protagenic Therapeutics Inc new  228,000.00 $ 1.368  Million 6 
Bristol myers Squibb Company  223,723.08 $ 7,271.000  Million 32,500 
Entrada Therapeutics Inc   221,947.37 $ 33.736  Million 152 


Date modified: 2026-09-23T16:04:42+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.